The Pennant Group (PNTG) Stock Price, News & Analysis

Company Overview

The Pennant Group, Inc. is a diversified transportation and logistics holding company that provides a range of freight services across North America. Through its wholly owned subsidiaries, Pennant offers asset-based truckload transportation, refrigerated services, intermodal drayage and chassis rental, freight brokerage, and specialized logistics solutions. The company’s organizational structure enables it to serve shippers of all sizes, handling dry van, temperature-controlled and specialized loads.

Key operating units include a dedicated common-carrier truckload division, a refrigerated carrier network, an intermodal and chassis services group, and a national freight brokerage arm. These businesses leverage a fleet of tractors and trailers as well as access to a nationwide network of third-party partners. Customers benefit from integrated tracking, cross-docking and transloading capabilities, along with tailored supply-chain consulting services designed to optimize shipment planning and reduce transit times.

Since its founding in the early 2000s, The Pennant Group has grown through strategic acquisitions and organic expansion, building critical mass in high-demand corridors and regional markets. Its development strategy has focused on acquiring complementary carriers and logistics providers to broaden service offerings and expand geographic coverage. Headquartered in Ohio, the company maintains terminals and service centers across the United States and Canada, enabling seamless cross-border operations and efficient gateway drayage.

The company is led by a seasoned executive team with deep industry experience. Under the leadership of its chief executive, Pennant continues to invest in technology, fleet modernization and strategic partnerships. By combining asset-based transportation with non-asset brokerage and value-added logistics, The Pennant Group aims to deliver end-to-end solutions that meet the evolving needs of shippers in food and beverage, retail, manufacturing and other key sectors.

Key Stats

• Today's Range: $25.75 to $26.53
• 50-Day Range: $25.42 to $30.22
• 52-Week Range: $21.18 to $37.13
• Volume: 291,495 shs
• Average Volume: 233,823 shs
• Market Capitalization: $891.05 million
• P/E Ratio: 34.01
• Dividend Yield: N/A
• Price Target: $34.60
• Consensus Rating: Moderate Buy

The Pennant Group Stock Analysis - MarketRank™

The Pennant Group scored higher than 71% of companies evaluated by MarketBeat, and ranked 256th out of 913 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

The Pennant Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 3 buy ratings, 2 hold ratings, and no sell ratings.

Amount of Analyst Coverage

The Pennant Group has only been the subject of 3 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 17.33%

Earnings Growth

Earnings for The Pennant Group are expected to grow by 17.33% in the coming year, from $0.75 to $0.88 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of The Pennant Group is 34.01, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.88.

Price to Earnings Ratio vs. Sector

The P/E ratio of The Pennant Group is 34.01, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.26.

Price to Earnings Growth Ratio

The Pennant Group has a PEG Ratio of 2.24. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

The Pennant Group has a P/B Ratio of 2.85. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.89% of the float of The Pennant Group has been sold short.

Short Interest Ratio / Days to Cover

The Pennant Group has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in The Pennant Group has recently increased by 5.95%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

The Pennant Group does not currently pay a dividend.

Dividend Growth

The Pennant Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

1.89% of the float of The Pennant Group has been sold short.

Short Interest Ratio / Days to Cover

The Pennant Group has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in The Pennant Group has recently increased by 5.95%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.7 / 5
• News Sentiment: 0.81

News Sentiment

The Pennant Group has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for The Pennant Group this week, compared to 4 articles on an average week.

Search Interest

5 people have searched for PNTG on MarketBeat in the last 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, The Pennant Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $164,387.00 in company stock.

Percentage Held by Insiders

Only 5.40% of the stock of The Pennant Group is held by insiders.

Percentage Held by Institutions

85.88% of the stock of The Pennant Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

PNTG Stock Analysis - Frequently Asked Questions

How have PNTG shares performed this year?

The Pennant Group's stock was trading at $26.52 at the start of the year. Since then, PNTG stock has decreased by 2.5% and is now trading at $25.85.

How were The Pennant Group's earnings last quarter?

The Pennant Group, Inc. (NASDAQ:PNTG) issued its earnings results on Wednesday, February, 28th. The company reported $0.18 EPS for the quarter, missing analysts' consensus estimates of $0.19 by $0.01. The business had revenue of $145.95 million for the quarter, compared to the consensus estimate of $136.79 million. The Pennant Group had a trailing twelve-month return on equity of 10.73% and a net margin of 3.40%.
Read the conference call transcript.

Who are The Pennant Group's major shareholders?

The Pennant Group's top institutional investors include Kings Path Partners LLC (0.05%). Insiders that own company stock include John G Nackel, Brent Guerisoli, John J Gochnour, Jennifer Freeman and Joanne Stringfield.
View institutional ownership trends.

How do I buy shares of The Pennant Group?

Shares of PNTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of The Pennant Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that The Pennant Group investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), ServiceNow (NOW), Palo Alto Networks (PANW) and Adobe (ADBE).

Company Calendar

• Last Earnings: 2/28/2024
• Today: 7/08/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - OUTP/HM CRE
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:PNTG
• CIK: 1766400
• Web: www.pennantgroup.com
• Phone: 208-506-6100
• Fax: N/A
• Employees: 7,000
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: $34.60
• High Stock Price Target: $38.00
• Low Stock Price Target: $31.00
• Potential Upside/Downside: +33.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 5 Analysts

Profitability

• EPS (Trailing Twelve Months): $0.76
• Trailing P/E Ratio: 34.01
• Forward P/E Ratio: 34.47
• P/E Growth: 2.24
• Net Income: $22.56 million
• Net Margins: 3.40%
• Pretax Margin: 4.80%
• Return on Equity: 10.73%
• Return on Assets: 4.00%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 1.41
• Quick Ratio: 1.41

Sales & Book Value

• Annual Sales: $695.24 million
• Price / Sales: 1.28
• Cash Flow: $0.91 per share
• Price / Cash Flow: 28.53
• Book Value: $9.08 per share
• Price / Book: 2.85

Miscellaneous

• Outstanding Shares: 34,470,000
• Free Float: 32,608,000
• Market Cap: $891.05 million
• Optionable: Optionable
• Beta: 1.51